|
TWSG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.9436999994863E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15270000000667E-06 |
| Normal-vs-Stage2 |
7.70609998035354E-09 |
| Normal-vs-Stage3 |
4.114000E-02 |
| Normal-vs-Stage4 |
2.995800E-01 |
| Stage1-vs-Stage2 |
9.572000E-02 |
| Stage1-vs-Stage3 |
7.202200E-02 |
| Stage1-vs-Stage4 |
1.536840E-01 |
| Stage2-vs-Stage3 |
1.926420E-02 |
| Stage2-vs-Stage4 |
1.472850E-01 |
| Stage3-vs-Stage4 |
8.585400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07699999996047E-06 |
| Normal-vs-AfricanAmerican |
1.180450E-04 |
| Normal-vs-Asian |
2.656600E-03 |
| Caucasian-vs-AfricanAmerican |
5.835800E-01 |
| Caucasian-vs-Asian |
6.449400E-01 |
| AfricanAmerican-vs-Asian |
5.170000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56129997819221E-10 |
| Normal-vs-Female |
1.077760E-02 |
| Male-vs-Female |
5.076200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.05920000000615E-05 |
| Normal-vs-Extreme_Weight |
1.02209996022395E-09 |
| Normal-vs-Obese |
8.592500E-04 |
| Normal-vs-Extreme_Obese |
1.517160E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.953000E-01 |
| Normal_Weight-vs-Obese |
5.420800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.439400E-01 |
| Extreme_Weight-vs-Obese |
8.328100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.238200E-01 |
| Obese-vs-Extreme_Obese |
5.280400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.432300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.79229999999853E-06 |
| Normal-vs-Age(61-80Yrs) |
8.80860000052053E-07 |
| Normal-vs-Age(81-100Yrs) |
9.973800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.780600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.656200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.828800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.420200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.898200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.741600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.15859602099067E-11 |
| Normal-VS-Type2 PRCC |
1.75270000002392E-06 |
| Normal-VS-KIRP CIMP |
5.298000E-01 |
| Normal-VS-Unclassified PRCC |
1.387170E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.083400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.941900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.297410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.178100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.939000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.022300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.58999999955567E-07 |
| Normal-vs-N1 |
3.293400E-01 |
| Normal-vs-N2 |
8.598000E-01 |
| N0-vs-N1 |
3.821100E-03 |
| N0-vs-N2 |
4.533000E-01 |
| N1-vs-N2 |
8.925400E-01 |
|
|
